Letter of Intent Deadline: Monday, June 26, 2023 View Request for Proposals Cures Within Reach has reopened the funding opportunity Requests for Proposal (RFP)…
The June 12th Community Research Advisory Council (C-RAC) networking dinner was a huge success! Congratulations to the C-RAC leadership: Roger, Pamela, Michael, Marlon, Joy,…
Study co-author Mary Jo Fackler, Ph.D., analyzes patient plasma samples. Credit: Madison Pleas A novel, automated liquid biopsy test in development by researchers at the Johns Hopkins…
This graphic shows the percent of cancer deaths from a second cancer among breast cancer survivors over time. Each color line represents a different race/ethnicity,…
The percentage of survivors of cancer reporting functional limitations in the United States has more than doubled over the past 20 years, according to a…
Johns Hopkins Technology Ventures (JHTV) is accepting inquiries for Maryland Innovation Initiative (MII) Funding as part of its effort to provide a continuum of funding to…
Visualizing connections between nerve cells in brains of mice is enabled by artificial intelligence. Thousands of SEP-GluA2 tagged synapses (green) surrounding a sparsely labeled dendrite…
Johns Hopkins Medicine team suggests that microparticle-delivered therapy may be first step toward stopping MS and other autoimmune diseases. MRI image in false colors of…
Johns Hopkins Medicine-led team shows technique can find protein fragments that best stimulate the immune system to recognize and attack the virus Since it…
In mice and human cell models, the drug 32-134D lowered protein levels known to contribute to diabetic macular edema and diabetic retinopathy. The research study…
